Andrew Jeremijenko

Research interests

Publications

• Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2203965

• Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

  Nature Communications · 2022 · https://doi.org/10.1038/s41467-022-30895-3

• Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2200797

• SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

  EClinicalMedicine · 2021 · https://doi.org/10.1016/j.eclinm.2021.100861

• Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar

  JAMA · 2021 · https://doi.org/10.1001/jama.2021.19623

• mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

  Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01446-y

• BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

  Nature Medicine · 2021 · https://doi.org/10.1038/s41591-021-01583-4

• Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting

  Clinical Infectious Diseases · 2020 · https://doi.org/10.1093/cid/ciaa1846

• Three Indonesian Clusters of H5N1 Virus Infection in 2005

  New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa060930

Current projects

No projects listed.